{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:39:41Z","timestamp":1790624381611,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08107-z","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:13:57Z","timestamp":1778087637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modeling metastasis and predicting drug response with malignant effusion-derived organoids: a systematic review and quantitative assessment"],"prefix":"10.1186","volume":"24","author":[{"given":"Jingyu","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7703-5346","authenticated-orcid":false,"given":"Yifang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"8","key":"8107_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186(8):1564\u201379. https:\/\/doi.org\/10.1016\/j.cell.2023.03.003.","journal-title":"Cell"},{"issue":"1","key":"8107_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbcan.2019.06.002","volume":"1872","author":"M Ale\u010dkovi\u0107","year":"2019","unstructured":"Ale\u010dkovi\u0107 M, McAllister SS, Polyak K. Metastasis as a systemic disease: molecular insights and clinical implications. Biochim Et Biophys Acta (BBA) - Rev Cancer. 2019;1872(1):89\u2013102. https:\/\/doi.org\/10.1016\/j.bbcan.2019.06.002.","journal-title":"Biochim Et Biophys Acta (BBA) - Rev Cancer"},{"issue":"3","key":"8107_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162\u201380. https:\/\/doi.org\/10.1038\/s41568-020-00320-2.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"8107_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1158\/2159-8290.CD-21-0010","volume":"11","author":"J Massague","year":"2021","unstructured":"Massague J, Ganesh K. Metastasis-initiating cells and ecosystems. Cancer Discov. 2021;11(4):971\u201394. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0010.","journal-title":"Cancer Discov"},{"issue":"10","key":"8107_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. Emt, met, plasticity, and tumor metastasis. Trends Cell Biol. 2020;30(10):764\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2020.07.003.","journal-title":"Trends Cell Biol"},{"issue":"23","key":"8107_CR6","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.devcel.2021.11.006","volume":"56","author":"F L\u00fc\u00f6nd","year":"2021","unstructured":"L\u00fc\u00f6nd F, Sugiyama N, Bill R, Bornes L, Hager C, Tang F, et al. Distinct contributions of partial and full emt to breast cancer malignancy. Dev Cell. 2021;56(23):3203\u201321.e11. https:\/\/doi.org\/10.1016\/j.devcel.2021.11.006.","journal-title":"Dev Cell"},{"issue":"10","key":"8107_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1568026620666200303123102","volume":"20","author":"DA Sabbah","year":"2020","unstructured":"Sabbah DA, Hajjo R, Sweidan K. Review on epidermal growth factor receptor (egfr) structure, signaling pathways, interactions, and recent updates of egfr inhibitors. CTMC. 2020;20(10):815\u201334. https:\/\/doi.org\/10.2174\/1568026620666200303123102.","journal-title":"CTMC"},{"key":"8107_CR8","doi-asserted-by":"publisher","unstructured":"Piffk\u00f3 A, Yang K, Panda A, Heide J, Tesak K, Wen C, et al. Publisher correction: radiation-induced amphiregulin drives tumour metastasis. Nature. 2025;647(8091):E9\u20139. https:\/\/doi.org\/10.1038\/s41586-025-09862-7.","DOI":"10.1038\/s41586-025-09862-7"},{"issue":"8","key":"8107_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-021-00375-9","volume":"21","author":"SA Kerk","year":"2021","unstructured":"Kerk SA, Papagiannakopoulos T, Shah YM, Lyssiotis CA. Metabolic networks in mutant kras-driven tumours: tissue specificities and the microenvironment. Nat Rev Cancer. 2021;21(8):510\u201325. https:\/\/doi.org\/10.1038\/s41568-021-00375-9.","journal-title":"Nat Rev Cancer"},{"issue":"7770","key":"8107_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","volume":"572","author":"MD Wellenstein","year":"2019","unstructured":"Wellenstein MD, Coffelt SB, Duits DEM, van Miltenburg MH, Slagter M, de Rink I, et al. Loss of p53 triggers wnt-dependent systemic inflammation to drive breast cancer metastasis. Nature. 2019;572(7770):538\u201342. https:\/\/doi.org\/10.1038\/s41586-019-1450-6.","journal-title":"Nature"},{"issue":"3","key":"8107_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE De Visser","year":"2023","unstructured":"De Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"issue":"3","key":"8107_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792\u2013809.e23. https:\/\/doi.org\/10.1016\/j.cell.2021.01.010.","journal-title":"Cell"},{"issue":"3","key":"8107_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer"},{"key":"8107_CR14","doi-asserted-by":"publisher","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024;16(728):eadg3840. https:\/\/doi.org\/10.1126\/scitranslmed.adg3840.","DOI":"10.1126\/scitranslmed.adg3840"},{"issue":"6","key":"8107_CR15","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836\u201348. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.009.","journal-title":"Cancer Cell"},{"key":"8107_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2023.05.003","volume":"93","author":"M Hu","year":"2023","unstructured":"Hu M, Kenific CM, Boudreau N, Lyden D. Tumor-derived nanoseeds condition the soil for metastatic organotropism. Semin Cancer Biol. 2023;93 (Elsevier, 70\u201382. https:\/\/doi.org\/10.1016\/j.semcancer.2023.05.003.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8107_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Lu Z, Wu S, Chu T, Li B, Qi F, et al. The dynamic role of platelets in cancer progression and their therapeutic implications. Nat Rev Cancer. 2024;24(1):72\u201387. https:\/\/doi.org\/10.1038\/s41568-023-00639-6.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"8107_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/HEP.0000000000000934","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Li T, Ding L, Wang J, Chen C, Liu T, et al. Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint cd155-tigit. Hepatology. 2025;81(3):791\u2013807. https:\/\/doi.org\/10.1097\/HEP.0000000000000934.","journal-title":"Hepatology"},{"issue":"3","key":"8107_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s43018-021-00181-0","volume":"2","author":"M Esposito","year":"2021","unstructured":"Esposito M, Ganesan S, Kang Y. Emerging strategies for treating metastasis. Nat Cancer. 2021;2(3):258\u201370. https:\/\/doi.org\/10.1038\/s43018-021-00181-0.","journal-title":"Nat Cancer"},{"issue":"7782","key":"8107_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299\u2013309. https:\/\/doi.org\/10.1038\/s41586-019-1730-1.","journal-title":"Nature"},{"issue":"7","key":"8107_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","volume":"20","author":"S Turajlic","year":"2019","unstructured":"Turajlic S, Sottoriva A, Graham T, Swanton C. Resolving genetic heterogeneity in cancer. Nat Rev Genet. 2019;20(7):404\u201316. https:\/\/doi.org\/10.1038\/s41576-019-0114-6.","journal-title":"Nat Rev Genet"},{"issue":"7467","key":"8107_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature12627","volume":"501","author":"PL Bedard","year":"2013","unstructured":"Bedard PL, Hansen AR, Ratain MJ, Siu LL. Tumour heterogeneity in the clinic. Nature. 2013;501(7467):355\u201364. https:\/\/doi.org\/10.1038\/nature12627.","journal-title":"Nature"},{"issue":"2","key":"8107_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394. https:\/\/doi.org\/10.1038\/nrclinonc.2017.166.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"8107_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","volume":"109","author":"LH Goetz","year":"2018","unstructured":"Goetz LH, Schork NJ. Personalized medicine: motivation, challenges, and progress. Fertil Steril. 2018;109(6):952\u201363. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.006.","journal-title":"Fertil Steril"},{"key":"8107_CR25","doi-asserted-by":"crossref","unstructured":"Hopkins CE. Emerging technologies in personalized medicine. 2023.","DOI":"10.1016\/j.mam.2023.101182"},{"issue":"4","key":"8107_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cels.2020.08.012","volume":"11","author":"R Quevedo","year":"2020","unstructured":"Quevedo R, Smirnov P, Tkachuk D, Ho C, El-Hachem N, Safikhani Z, et al. Assessment of genetic drift in large pharmacogenomic studies. Cell Syst. 2020;11(4):393\u2013401.e2. https:\/\/doi.org\/10.1016\/j.cels.2020.08.012.","journal-title":"Cell Syst"},{"issue":"1","key":"8107_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Sig Transduct Target Ther. 2023;8(1):160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"8107_CR28","first-page":"259","volume":"189","author":"J Wang","year":"2022","unstructured":"Wang J, Feng X, Li Z, Chen Y, Huang W. Patient-derived organoids as a model for tumor research. Prog Mol Biol Transl Sci. 2022;189(1):259\u2013326.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"6","key":"8107_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJMra1806175","volume":"380","author":"M Li","year":"2019","unstructured":"Li M, Belmonte JCI. Organoids\u2014preclinical models of human disease. N Engl J Med. 2019;380(6):569\u201379. https:\/\/doi.org\/10.1056\/NEJMra1806175.","journal-title":"N Engl J Med"},{"issue":"1","key":"8107_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH, et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell. 2020;180(1):188\u2013204.e22. https:\/\/doi.org\/10.1016\/j.cell.2019.11.036.","journal-title":"Cell"},{"issue":"2","key":"8107_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","volume":"21","author":"BL LeSavage","year":"2022","unstructured":"LeSavage BL, Suhar RA, Broguiere N, Lutolf MP, Heilshorn SC. Next-generation cancer organoids. Nat Mater. 2022;21(2):143\u201359. https:\/\/doi.org\/10.1038\/s41563-021-01057-5.","journal-title":"Nat Mater"},{"issue":"6378","key":"8107_CR32","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fern\u00e1ndez-Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359(6378):920\u201326. https:\/\/doi.org\/10.1126\/science.aao2774.","journal-title":"Science"},{"issue":"1","key":"8107_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao Y, Xu X, Yang L, Zhu J, Wan J, Shen L, et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell STEM Cell. 2020;26(1):17\u201326.e6. https:\/\/doi.org\/10.1016\/j.stem.2019.10.010.","journal-title":"Cell STEM Cell"},{"key":"8107_CR34","doi-asserted-by":"publisher","unstructured":"Chen P, Zhang X, Ding R, Yang L, Lyu X, Zeng J, et al. Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer. Adv Sci. 2021;8(22), 2101176 (https:\/\/doi.org\/10.1002\/advs.202101176.","DOI":"10.1002\/advs.202101176"},{"key":"8107_CR35","doi-asserted-by":"crossref","unstructured":"Duong V, Hargreaves B, Muruganandan S. Management of malignant pleural effusion in 2024: a definitive and unified global approach. 2025.","DOI":"10.1200\/OP-24-00925"},{"key":"8107_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-94-007-4783-8_2","volume-title":"Malignant effusions: pleuritis, ascites, Pericardites","author":"IO Chikileva","year":"2012","unstructured":"Chikileva IO, Anisimova NY, Shubina IZ, Kiselevsky MV. Malignant effusions: pleuritis, ascites, Pericardites. Springer; 2012. p. 11\u201321."},{"issue":"1","key":"8107_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41467-023-36310-9","volume":"14","author":"XZ Huang","year":"2023","unstructured":"Huang XZ, Pang MJ, Li JY, Chen HY, Sun JX, Song YX, et al. Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis. Nat Commun. 2023;14(1):822. https:\/\/doi.org\/10.1038\/s41467-023-36310-9.","journal-title":"Nat Commun"},{"issue":"1","key":"8107_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40164-024-00581-9","volume":"13","author":"L Wang","year":"2024","unstructured":"Wang L, Yu Y, Fang Y, Li Y, Yu W, Wang Z, et al. Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources. Exp Hematol Oncol. 2024;13(1):115. https:\/\/doi.org\/10.1186\/s40164-024-00581-9.","journal-title":"Exp Hematol Oncol"},{"key":"8107_CR39","doi-asserted-by":"publisher","first-page":"104285","DOI":"10.1016\/j.critrevonc.2024.104285","volume":"195","author":"S Seghers","year":"2024","unstructured":"Seghers S, Compte ML, Hendriks JMH, Van Schil P, Janssens A, Wener R, et al. A systematic review of patient-derived tumor organoids generation from malignant effusions. Crit Rev Oncol\/Hematol. 2024;195, 104285 (104285. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104285.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"7","key":"8107_CR40","first-page":"957","volume":"17","author":"K Kelly","year":"2003","unstructured":"Kelly K. The benefits of achieving stable disease in advanced lung cancer. Oncol (Williston Park, NY). 2003;17(7):957\u201363.","journal-title":"Oncol (Williston Park, NY)"},{"issue":"7","key":"8107_CR41","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1556-0864(15)30382-8","volume":"1","author":"T Kurata","year":"2006","unstructured":"Kurata T, Matsuo K, Takada M, Kawahara M, Tsuji M, Matsubara Y, et al. Is the importance of achieving stable disease different between epidermal growth factor receptor tyrosine kinase inhibitors and cytotoxic agents in the second-line setting for advanced non-small cell lung cancer? J Thorac Oncol. 2006;1(7):684\u201391. https:\/\/doi.org\/10.1016\/S1556-0864(15)30382-8.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"8107_CR42","doi-asserted-by":"publisher","first-page":"100911","DOI":"10.1016\/j.xcrm.2022.100911","volume":"4","author":"HM Wang","year":"2023","unstructured":"Wang HM, Zhang CY, Peng KC, Chen ZX, Su JW, Li YF, et al. Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study. Cell Rep. Med. 2023;4(2):100911. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100911.","journal-title":"Cell Rep. Med"},{"issue":"1","key":"8107_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41698-024-00609-7","volume":"8","author":"SH Lee","year":"2024","unstructured":"Lee SH, Kim K, Lee E, Lee K, Ahn KH, Park H, et al. Prediction of tki response in egfr-mutant lung cancer patients-derived organoids using malignant pleural effusion. npj Precis. Onc. 2024;8(1):111. https:\/\/doi.org\/10.1038\/s41698-024-00609-7.","journal-title":"npj Precis. Onc"},{"key":"8107_CR44","doi-asserted-by":"publisher","unstructured":"Suzuki S, Hisata T, Suzuki T, Hisata S, Fujita K, Fujiwara S, et al. Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer. Heliyon. 2023;9(3):e13829. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13829.","DOI":"10.1016\/j.heliyon.2023.e13829"},{"issue":"11","key":"8107_CR45","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/1759-7714.14429","volume":"13","author":"KC Peng","year":"2022","unstructured":"Peng KC, Su JW, Xie Z, Wang HM, Fang MM, Li WF, et al. Clinical outcomes of egfr+\/met amp+ vs. egfr+\/met amp-untreated patients with advanced non-small cell lung cancer. Thorac Cancer. 2022;13(11):1619\u201330. https:\/\/doi.org\/10.1111\/1759-7714.14429.","journal-title":"Thorac Cancer"},{"issue":"11","key":"8107_CR46","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.21037\/tlcr-22-163","volume":"11","author":"F Ruzzi","year":"2022","unstructured":"Ruzzi F, Angelicola S, Landuzzi L, Nironi E, Semprini MS, Scalambra L, et al. Adk-vr2, a cell line derived from a treatment-na\u00efve patient with sdc4-ros1 fusion-positive primarily crizotinib-resistant nsclc: a novel preclinical model for new drug development of ros1-rearranged nsclc. Transl Lung Cancer Res. 2022;11(11):2216. https:\/\/doi.org\/10.21037\/tlcr-22-163.","journal-title":"Transl Lung Cancer Res"},{"issue":"4","key":"8107_CR47","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1007\/s13577-024-01060-3","volume":"37","author":"M Iwai","year":"2024","unstructured":"Iwai M, Yokota E, Ishida Y, Yukawa T, Naomoto Y, Monobe Y, et al. Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma. Hum Cell. 2024;37(4):1194\u2013204. https:\/\/doi.org\/10.1007\/s13577-024-01060-3.","journal-title":"Hum Cell"},{"key":"8107_CR48","doi-asserted-by":"publisher","unstructured":"Hyung S, Ko J, Heo YJ, Blum SM, Kim ST, Park SH, et al. Patient-derived exosomes facilitate therapeutic targeting of oncogenic met in advanced gastric cancer. Sci Adv. 2023;9(47):eadk1098. https:\/\/doi.org\/10.1126\/sciadv.adk1098.","DOI":"10.1126\/sciadv.adk1098"},{"issue":"3","key":"8107_CR49","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1245\/s10434-023-14696-6","volume":"31","author":"SN Radomski","year":"2024","unstructured":"Radomski SN, Dunworth M, West JJ, Greer JB, Johnston FM, Ewald AJ. Intra- and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for nongynecologic cancers. Ann Surg Oncol. 2024;31(3):1996\u20132007. https:\/\/doi.org\/10.1245\/s10434-023-14696-6.","journal-title":"Ann Surg Oncol"},{"key":"8107_CR50","doi-asserted-by":"publisher","unstructured":"Xu H, Hao Z, Wang Y, Zhang D, Li J, Chen L, et al. Liquid tumor microenvironment enhances wnt signaling pathway of peritoneal metastasis of gastric cancer. Sci Rep. 2023;13(1), 11125 (https:\/\/doi.org\/10.1038\/s41598-023-38373-6.","DOI":"10.1038\/s41598-023-38373-6"},{"issue":"4","key":"8107_CR51","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4143\/crt.2022.1630","volume":"55","author":"W Choi","year":"2023","unstructured":"Choi W, Kim YH, Woo SM, Yu Y, Lee MR, Lee WJ, et al. Establishment of patient-derived organoids using ascitic or pleural fluid from cancer patients. Cancer Res Treat. 2023;55(4):1077\u201386. https:\/\/doi.org\/10.4143\/crt.2022.1630.","journal-title":"Cancer Res Treat"},{"issue":"14","key":"8107_CR52","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.3390\/cancers15143602","volume":"15","author":"CE \u00d6nder","year":"2023","unstructured":"\u00d6nder CE, Ziegler TJ, Becker R, Brucker SY, Hartkopf AD, Engler T, et al. Advancing cancer therapy predictions with patient-derived organoid models of metastatic breast cancer. Cancers. 2023;15(14):3602. https:\/\/doi.org\/10.3390\/cancers15143602.","journal-title":"Cancers"},{"issue":"5","key":"8107_CR53","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s11626-021-00563-9","volume":"57","author":"B Pan","year":"2021","unstructured":"Pan B, Zhao D, Liu Y, Li N, Song C, Li N, et al. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform. In Vitro Cell.Dev.Biol.-Anim. 2021;57(5):510\u201318. https:\/\/doi.org\/10.1007\/s11626-021-00563-9.","journal-title":"In Vitro Cell.Dev.Biol.-Anim"},{"issue":"3","key":"8107_CR54","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41418-021-00878-w","volume":"29","author":"T Velletri","year":"2022","unstructured":"Velletri T, Villa CE, Cilli D, Barzaghi B, Riso PL, Lupia M, et al. Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer. Cell Death Differ. 2022;29(3):614\u201326. https:\/\/doi.org\/10.1038\/s41418-021-00878-w.","journal-title":"Cell Death Differ"},{"key":"8107_CR55","doi-asserted-by":"publisher","unstructured":"Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, et al. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS One. 2014;9(1):e84941. https:\/\/doi.org\/10.1371\/journal.pone.0084941.","DOI":"10.1371\/journal.pone.0084941"},{"issue":"6","key":"8107_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.cels.2023.05.003","volume":"14","author":"DB Morse","year":"2023","unstructured":"Morse DB, Michalowski AM, Ceribelli M, De Jonghe J, Vias M, Riley D, et al. Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics. Cell Syst. 2023;14(6):464\u201381.e7. https:\/\/doi.org\/10.1016\/j.cels.2023.05.003.","journal-title":"Cell Syst"},{"issue":"10","key":"8107_CR57","first-page":"1","volume":"9","author":"OB Ahmad","year":"2001","unstructured":"Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M, et al. Age standardization of rates: a new who standard. Geneva: World Health Organ. 2001;9(10):1\u201314.","journal-title":"Geneva: World Health Organ"},{"issue":"10","key":"8107_CR58","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.amjmed.2022.04.017","volume":"135","author":"S Gayen","year":"2022","unstructured":"Gayen S. Malignant pleural effusion: presentation, diagnosis, and management. Am J Med. 2022;135(10):1188\u201392. https:\/\/doi.org\/10.1016\/j.amjmed.2022.04.017.","journal-title":"Am J Med"},{"key":"8107_CR59","doi-asserted-by":"publisher","first-page":"217738","DOI":"10.1016\/j.canlet.2025.217738","volume":"625","author":"D Duraki","year":"2025","unstructured":"Duraki D, Jabeen M, Mao C, Wang L, Ghosh S, Dai X, et al. A necrosis inducer promotes an immunogenic response and destroys ovarian cancers in mouse xenografts and patient ascites organoids. Cancer Lett p. 217738 (2025;625:217738. https:\/\/doi.org\/10.1016\/j.canlet.2025.217738.","journal-title":"Cancer Lett"},{"key":"8107_CR60","first-page":"657","volume":"32","author":"B Zhao","year":"2022","unstructured":"Zhao B, Song W, Wang H. Chinese experts consensus on quality control standards for tumor organoids diagnosis and treatment platform (2022 version). China Oncol. 2022;32:657\u201368.","journal-title":"China Oncol"},{"issue":"5","key":"8107_CR61","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","volume":"26","author":"R Shi","year":"2020","unstructured":"Shi R, Radulovich N, Ng C, Liu N, Notsuda H, Cabanero M, et al. Organoid cultures as preclinical models of non\u2013small cell lung cancer. Clin Cancer Res. 2020;26(5):1162\u201374. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1376.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"8107_CR62","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","volume":"28","author":"A Marsee","year":"2021","unstructured":"Marsee A, Roos FJM, Verstegen MMA, Marsee A, Roos F, Verstegen M, et al. Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell STEM Cell. 2021;28(5):816\u201332. https:\/\/doi.org\/10.1016\/j.stem.2021.04.005.","journal-title":"Cell STEM Cell"},{"issue":"3","key":"8107_CR63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF02905254","volume":"4","author":"A Albini","year":"1998","unstructured":"Albini A. Tumor and endothelial cell invasion of basement membranes: the matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol. Oncol. Res. 1998;4(3):230\u201341. https:\/\/doi.org\/10.1007\/BF02905254.","journal-title":"Pathol. Oncol. Res"},{"key":"8107_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2019.00107","volume":"7","author":"J Pijuan","year":"2019","unstructured":"Pijuan J, Barcel\u00f3 C, Moreno DF, Maiques O, Sis\u00f3 P, Marti RM, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front. Cell Dev. Biol. 2019;7:107. https:\/\/doi.org\/10.3389\/fcell.2019.00107.","journal-title":"Front. Cell Dev. Biol"},{"issue":"7","key":"8107_CR65","doi-asserted-by":"publisher","first-page":"101627","DOI":"10.1016\/j.xcrm.2024.101627","volume":"5","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li S, Zhu L, Huang M, Xie Y, Song X, et al. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer. Cell Rep. Med. 2024;5(7):101627. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101627.","journal-title":"Cell Rep. Med"},{"issue":"24","key":"8107_CR66","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1111\/febs.70216","volume":"292","author":"Y Bai","year":"2025","unstructured":"Bai Y, Blyth B, Boath J, Deng Q, Huang R, Darido C. A patient-derived orthotopic xenograft model unveils metastatic dynamics in head and neck squamous cell carcinoma. The FEBS J. 2025;292(24):6696\u2013709. https:\/\/doi.org\/10.1111\/febs.70216.","journal-title":"The FEBS J"},{"issue":"8036","key":"8107_CR67","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"CK Mo","year":"2024","unstructured":"Mo CK, Liu J, Chen S, Storrs E, da Costa ALN, Houston A, et al. Tumour evolution and microenvironment interactions in 2d and 3d space. Nature. 2024;634(8036):1178\u201386. https:\/\/doi.org\/10.1038\/s41586-024-08087-4.","journal-title":"Nature"},{"issue":"11","key":"8107_CR68","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41591-024-03215-z","volume":"30","author":"J Klughammer","year":"2024","unstructured":"Klughammer J, Abravanel DL, Segerstolpe \u00c5, Blosser TR, Goltsev Y, Cui Y, et al. A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features. Nat Med. 2024;30(11):3236\u201349. https:\/\/doi.org\/10.1038\/s41591-024-03215-z.","journal-title":"Nat Med"},{"issue":"7781","key":"8107_CR69","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley P, Baber J, Lolkema MP, Steeghs N, De Bruijn E, Shale C, et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature. 2019;575(7781):210\u201316. https:\/\/doi.org\/10.1038\/s41586-019-1689-y.","journal-title":"Nature"},{"issue":"10","key":"8107_CR70","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1113205.","journal-title":"N Engl J Med"},{"issue":"8","key":"8107_CR71","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.7150\/thno.96027","volume":"14","author":"D Xiang","year":"2024","unstructured":"Xiang D, He A, Zhou R, Wang Y, Xiao X, Gong T, et al. Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development. Theranostics. 2024;14(8):3300. https:\/\/doi.org\/10.7150\/thno.96027.","journal-title":"Theranostics"},{"issue":"6","key":"8107_CR72","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3390\/cancers14061415","volume":"14","author":"G Karpathiou","year":"2022","unstructured":"Karpathiou G, P\u00e9oc\u2019h M, Sundaralingam A, Rahman N, Froudarakis ME. Inflammation of the pleural cavity: a review on pathogenesis, diagnosis and implications in tumor pathophysiology. Cancers. 2022;14(6):1415. https:\/\/doi.org\/10.3390\/cancers14061415.","journal-title":"Cancers"},{"issue":"1","key":"8107_CR73","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccm.2017.11.004","volume":"39","author":"R Asciak","year":"2018","unstructured":"Asciak R, Rahman NM. Malignant pleural effusion: from diagnostics to therapeutics. Clin Chest Med. 2018;39(1):181\u201393. https:\/\/doi.org\/10.1016\/j.ccm.2017.11.004.","journal-title":"Clin Chest Med"},{"issue":"8","key":"8107_CR74","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMra1403503","volume":"378","author":"D Feller-Kopman","year":"2018","unstructured":"Feller-Kopman D, Light R. Pleural disease. N Engl J Med. 2018;378(8):740\u201351. https:\/\/doi.org\/10.1056\/NEJMra1403503.","journal-title":"N Engl J Med"},{"issue":"4","key":"8107_CR75","doi-asserted-by":"publisher","first-page":"842","DOI":"10.21037\/apm-23-554","volume":"13","author":"T Ikegami","year":"2024","unstructured":"Ikegami T, Ishiki H, Kadono T, Ito T, Yokomichi N. Narrative review of malignant ascites: epidemiology, pathophysiology, assessment, and treatment. Ann Palliat Med. 2024;13(4):842\u201357. https:\/\/doi.org\/10.21037\/apm-23-554.","journal-title":"Ann Palliat Med"},{"issue":"1","key":"8107_CR76","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi X, Wang X, Yao W, Shi D, Shao X, Lu Z, et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Sig Transduct Target Ther. 2024;9(1):192. https:\/\/doi.org\/10.1038\/s41392-024-01885-2.","journal-title":"Sig Transduct Target Ther"},{"key":"8107_CR77","doi-asserted-by":"publisher","unstructured":"Krishna R. US FDA\u2019s strategic transition of animal to non-animal alternatives for monoclonal antibody development: a much needed fuel to incentivize innovation. J Clin Pharmacol. 2026;66(3). https:\/\/doi.org\/10.1002\/jcph.70127.","DOI":"10.1002\/jcph.70127"},{"issue":"7","key":"8107_CR78","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407\u201318. https:\/\/doi.org\/10.1038\/s41568-018-0007-6.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8107_CR79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chest.2018.03.034","volume":"154","author":"SJ Millington","year":"2018","unstructured":"Millington SJ, Koenig S. Better with ultrasound: paracentesis. Chest. 2018;154(1):177\u201384. https:\/\/doi.org\/10.1016\/j.chest.2018.03.034.","journal-title":"Chest"},{"issue":"2","key":"8107_CR80","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/cam4.4973","volume":"12","author":"P Qi","year":"2023","unstructured":"Qi P, Sun Y, Liu X, Wu S, Wo Y, Xu Q, et al. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: an analysis of 1420 cases. Cancer Med. 2023;12(2):1177\u201388. https:\/\/doi.org\/10.1002\/cam4.4973.","journal-title":"Cancer Med"},{"issue":"5","key":"8107_CR81","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/s41591-024-02915-w","volume":"30","author":"F Tian","year":"2024","unstructured":"Tian F, Liu D, Wei N, Fu Q, Sun L, Liu W, et al. Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning. Nat Med. 2024;30(5):1309\u201319. https:\/\/doi.org\/10.1038\/s41591-024-02915-w.","journal-title":"Nat Med"},{"key":"8107_CR82","doi-asserted-by":"publisher","unstructured":"Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L, et al. Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. MedComm. 2024;5(10):e735. https:\/\/doi.org\/10.1002\/mco2.735.","DOI":"10.1002\/mco2.735"},{"issue":"1","key":"8107_CR83","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1038\/s41467-021-27026-9","volume":"12","author":"ZY Huang","year":"2021","unstructured":"Huang ZY, Shao MM, Zhang JC, Yi FS, Du J, Zhou Q, et al. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion. Nat Commun. 2021;12(1):6690. https:\/\/doi.org\/10.1038\/s41467-021-27026-9.","journal-title":"Nat Commun"},{"issue":"1","key":"8107_CR84","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12931-025-03263-0","volume":"26","author":"Q Cheng","year":"2025","unstructured":"Cheng Q, Zuo X, Wang Z, Lu W, Jiang Y, Liu J, et al. Intrapleural dual blockade of il-6 and pd-l1 reprograms caf dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion. Respir Res. 2025;26(1):180. https:\/\/doi.org\/10.1186\/s12931-025-03263-0.","journal-title":"Respir Res"},{"issue":"1","key":"8107_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","volume":"15","author":"CM Cattaneo","year":"2020","unstructured":"Cattaneo CM, Dijkstra KK, Fanchi LF, Kelderman S, Kaing S, van Rooij N, et al. Tumor organoid\u2013t-cell coculture systems. Nat Protoc. 2020;15(1):15\u201339. https:\/\/doi.org\/10.1038\/s41596-019-0232-9.","journal-title":"Nat Protoc"},{"issue":"7","key":"8107_CR86","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175(7):1972\u201388.e16. https:\/\/doi.org\/10.1016\/j.cell.2018.11.021.","journal-title":"Cell"},{"issue":"6","key":"8107_CR87","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.chom.2021.04.002","volume":"29","author":"J Puschhof","year":"2021","unstructured":"Puschhof J, Pleguezuelos-Manzano C, Clevers H. Organoids and organs-on-chips: insights into human gut-microbe interactions. Cell Host Microbe. 2021;29(6):867\u201378. https:\/\/doi.org\/10.1016\/j.chom.2021.04.002.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"8107_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","volume":"20","author":"LA Low","year":"2021","unstructured":"Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. Organs-on-chips: into the next decade. Nat Rev Drug Discov. 2021;20(5):345\u201361. https:\/\/doi.org\/10.1038\/s41573-020-0079-3.","journal-title":"Nat Rev Drug Discov"},{"key":"8107_CR89","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bioactmat.2023.09.005","volume":"31","author":"L Bai","year":"2024","unstructured":"Bai L, Wu Y, Li G, Zhang W, Zhang H, Su J. Ai-enabled organoids: construction, analysis, and application. Bioact Mater. 2024;31:525\u201348. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.09.005.","journal-title":"Bioact Mater"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08107-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08107-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08107-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:02:07Z","timestamp":1778166127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08107-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8107"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08107-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"649"}}